Failure of moxifloxacin treatment in Mycoplasma genitalium infections due to macrolide and fluoroquinolone resistance
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
Increasing azithromycin treatment failure in sexually transmitted Mycoplasma genitalium infection, is linked to macrolide resistance and second-line treatment relies on the fluoroquinolone, moxifloxacin. We recently detected fluoroquinolone and macrolide resistance-associated mutations in 15% and 43%, respectively, of 143 initial M. genitalium PCR-positive specimens. For a subset of 33 Western Sydney Sexual Health Centre patients, clinical information and results of sequence analysis of M. genitalium macrolide and fluoroquinolone target genes – the 23S rRNA gene, and parC and gyrA, respectively – were used to examine whether mutations were associated with treatment failure. Macrolide resistance-associated mutations correlated with microbiological ( p = 0.013) and clinical ( p = 0.024) treatment failure, and fluoroquinolone resistance-associated mutations with microbiological moxifloxacin treatment failure ( p = 0.005). We describe the first reported cases of clinical and microbiological moxifloxacin treatment failure. Failure of first- and second-line antibiotic treatment of M. genitalium infection is occurring and likely to increase with current treatment strategies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bradshaw, C. S., Tabrizi, S. N., Read, T. R. H., Garland, S. M., Hopkins, C. A., Moss, L. M., & Fairley, C. K. (2006) · The Journal of Infectious Diseases · doi:10.1086/499434 · Cited by 284
Cited by
Sexually Transmitted Diseases Treatment Guidelines, 2010
(2011) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2011.04.006 · Cited by 2,076
2016 European guideline on Mycoplasma genitalium infections
Jensen, J. S., Cusini, M., Gomberg, M., & Moi, H. (2016) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.13849 · Cited by 343
Machalek, D. A., Tao, Y., Shilling, H., Jensen, J. S., Unemo, M., Murray, G., Chow, E. P. F., Low, N., Garland, S. M., Vodstrcil, L. A., et al. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30154-7 · Cited by 273
2021 European guideline on the management of Mycoplasma genitalium infections
Jensen, J. S., Cusini, M., Gomberg, M., Moi, H., Wilson, J., & Unemo, M. (2022) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.17972 · Cited by 255
Read, T. R. H., Fairley, C. K., Murray, G. L., Jensen, J. S., Danielewski, J., Worthington, K., Doyle, M., Mokany, E., Tan, L., Chow, E. P. F., et al. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciy477 · Cited by 216
“genitalium infections can be cured in a population where two-thirds of cases are macrolide resistant and 20% of macrolide-resistant cases are likely quinolone resistant [15, 17].”
Background
Metadata
- Authors
- Couldwell, D. L., Tagg, K. A., Jeoffreys, N. J., & Gilbert, G. L.
- Venue
- International Journal of STD & AIDS
- Publisher
- SAGE Publications
- Published
- 2013-08-29
- Volume
- 24
- Issue
- 10
- Pages
- 822-828
- ISSN
- 0956-4624 (ISSN-L)
- 1758-1052
- OpenAlex
- W2080798045
- Cited by
- 153
- References
- 1
- FWCI
- 9.96
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Failure of moxifloxacin treatment in Mycoplasma genitalium infections due to macrolide and fluoroquinolone resistance. https://app.cochat.ai/papers/10.1177/0956462413502008
- The paper
- Couldwell, D. L., Tagg, K. A., Jeoffreys, N. J., & Gilbert, G. L. (2013). Failure of moxifloxacin treatment in Mycoplasma genitalium infections due to macrolide and fluoroquinolone resistance. International Journal of STD & AIDS. https://doi.org/10.1177/0956462413502008
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.